| Name | microRNA 664b |
| Description | microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nAberrant expression of microRNAs plays a fundamental role in cancer development and progression."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In cutaneous squamous cell carcinoma, for example, altered levels of miR‐664 have been implicated in tumor growth and metastasis, although its precise function in this cancer type remains to be fully elucidated."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": " In laryngeal squamous cell carcinoma, investigation of the RASSF8‐AS1/miR‐664b‐3p/TLE1 axis revealed that the long noncoding RNA RASSF8‐AS1 acts as a sponge to sequester miR‐664b‐3p; this leads to upregulation of TLE1 and suppression of cell migration, invasion, and proliferation, underscoring a critical modulatory role for miR‐664b‐3p in tumor progression."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " In a related study focusing on cSCC, other regulatory factors such as ARMC8 were examined, highlighting the broader complexity of microRNA‐associated networks in similar tumor contexts."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn hepatocellular carcinoma, miR‐664b‐5p was found to be downregulated, and restoration of its levels suppressed cell viability, migration, and invasion while promoting apoptosis through negative regulation of AKT2, indicating a tumor‐suppressive function."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": " Consistent with this tumor‐inhibitory role, in pancreatic cancer the long noncoding RNA HOXD‐AS1 was shown to be upregulated and to promote proliferation, invasion, and migration by sponging miR‐664b‐3p, thereby preventing miR‐664b‐3p from repressing its target PLAC8."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": " Similarly, analysis in colon cancer demonstrated that overexpression of miR‐664b‐3p inhibited proliferation, migration, and invasion and induced apoptosis by downregulating Bub3 protein expression."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": " Together, these studies indicate that miR‐664b (whether as the 3p or 5p isoform) exerts context‐dependent regulatory functions, acting predominantly as a tumor suppressor in hepatocellular, pancreatic, and colon cancers while its deregulation in squamous cell carcinomas may contribute to oncogenic processes.\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Bin Chen, Yongzheng Bao, Xiaoming Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mir-664 promotes osteosarcoma cells proliferation via downregulating of FOXO4."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2015.08.012"}], "href": "https://doi.org/10.1016/j.biopha.2015.08.012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26463624"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26463624"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Xiangzhi Li, Cheng Zhou, Chen Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-664 functions as an oncogene in cutaneous squamous cell carcinomas (cSCC) via suppressing interferon regulatory factor 2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Dermatol Sci (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jdermsci.2019.05.004"}], "href": "https://doi.org/10.1016/j.jdermsci.2019.05.004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31138473"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31138473"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Tao Liu, Wenxia Meng, Huan Cao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "lncRNA RASSF8‑AS1 suppresses the progression of laryngeal squamous cell carcinoma via targeting the miR‑664b‑3p/TLE1 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2020.7771"}], "href": "https://doi.org/10.3892/or.2020.7771"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33000257"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33000257"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Xiangzhi Li, Chen Zhang, Yawen Yuan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Downregulation of ARMC8 promotes tumorigenesis through activating Wnt/β-catenin pathway and EMT in cutaneous squamous cell carcinomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Dermatol Sci (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jdermsci.2021.05.002"}], "href": "https://doi.org/10.1016/j.jdermsci.2021.05.002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34016486"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34016486"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Hongwei Li, Dawei Guo, Yuhong Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-664b-5p Inhibits Hepatocellular Cancer Cell Proliferation Through Targeting Oncogene AKT2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Biother Radiopharm (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1089/cbr.2019.3043"}], "href": "https://doi.org/10.1089/cbr.2019.3043"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31967930"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31967930"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Liang Chen, Wenyang Niu, Dongmei Zhu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA HOXD-AS1 promotes the progression of pancreatic cancer through miR-664b-3p/PLAC8 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pathol Res Pract (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.prp.2022.153836"}], "href": "https://doi.org/10.1016/j.prp.2022.153836"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35279480"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35279480"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Liang-Yu Zhao, Guo-Jun Xin, Yuan-Yuan Tang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-664b-3p inhibits colon cell carcinoma via negatively regulating Budding uninhibited by benzimidazole 3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Bioengineered (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/21655979.2022.2036400"}], "href": "https://doi.org/10.1080/21655979.2022.2036400"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35156516"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35156516"}]}]}]}
|
| Synonyms | MIR-664B, HSA-MIR-664B, MIR644B |
| NCBI Gene ID | 100847052 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MIR664B has 133 functional associations with biological entities spanning 1 categories (cell line, cell type or tissue) extracted from 2 datasets.
Click the + buttons to view associations for MIR664B from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR664B gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR664B gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |